Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
Lower urinary tract symptoms of neurological origin in urological practice.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
The effects of bortezomib on the immune system: a focus on immune regulation.
Functional plasticity of the visual system in multiple sclerosis.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
The genetics of multiple sclerosis: review of current and emerging candidates.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Intractable hiccup caused by spinal cord lesions in demyelination disease.
Dysphagia in stroke, neurodegenerative disease, and advanced dementia.
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.
Pages
« first
‹ previous
…
326
327
328
329
330
331
332
333
334
…
next ›
last »